Cargando…
Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET(®) Medical Information Database Network in Japan
An association between kidney disease and direct-acting antivirals against hepatitis C (DAAs) has been suggested, however the warning on the package insert (PI) of the drug varies among DAAs. In this study, the risk of decreased kidney function associated with DAAs marketed in Japan was investigated...
Autores principales: | Hasegawa, Tomoaki, Sawada, Sono, Ishiguro, Chieko, Ando, Takashi, Kobayashi, Kanae, Komiyama, Noriyuki, Iguchi, Toyotaka, Nonaka, Takahiro, Uyama, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135840/ https://www.ncbi.nlm.nih.gov/pubmed/35437631 http://dx.doi.org/10.1007/s43441-022-00400-5 |
Ejemplares similares
-
Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET(®)) in Japan
por: Sawada, Sono, et al.
Publicado: (2021) -
Nested Case‐Control Study Utilizing MID‐NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents
por: Kajiyama, Kazuhiro, et al.
Publicado: (2021) -
Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan
por: Shida, Haruka, et al.
Publicado: (2023) -
Cardiovascular risk of urate‐lowering drugs: A study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Sawada, Sono, et al.
Publicado: (2022) -
Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan
por: Nishioka, Kinue, et al.
Publicado: (2021)